Clinical Trials Browser

Phase 2/3 × Axitinib × Endocrine × Clear all

NCT01744249 2026-04-28

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Phase 2/3 Completed

256 enrolled 25 charts

Neuroendocrine Tumors